Guggenheim Starts BrightSpring Health (BTSG) at Buy

July 13, 2026 6:10 AM

Guggenheim analyst Jason Cassorla initiates coverage on BrightSpring Health (NASDAQ: BTSG) with a Buy rating and a price target of $81.00.

For an analyst ratings summary and ratings history on BrightSpring Health click here. For more ratings news on BrightSpring Health click here.